Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 481-492 of 1,909
Behavioral study icon
CompletedNCT02003690

Dialectical Behavior Therapy (DBT) for Adolescents With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Drug study icon
CompletedNCT00156325

Escitalopram as a Mood Stabilizer for Bipolarity type II

This summary needs review. Please check the official study record and contact the research team for details.

In Sydney
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
The University of New South Wales
Condition
Bipolarity
Drug study icon
TerminatedNCT00047567

Adjunctive Zonisamide for Bipolarity

This study was terminated. It is testing Open-label Adjunctive Zonisamide for Bipolarity.

Location not clearly listed
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 6 Years to 17 Years
Countries
Sponsor
Elan Pharmaceuticals
Condition
Bipolarity
Drug study icon
CompletedNCT01188148

Series Studies of Bipolarity-Valproate add-on Memantine

This summary needs review. Please check the official study record and contact the research team for details.

In Tainan
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
National Cheng-Kung University Hospital
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2004-000687-27

A 52 week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2500 mg/d in the treatment of manic episodes of Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Austria, Czechia, Slovakia
Sponsor
Novartis Pharma AG
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2004-000686-35

A 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of Bipolarity type I

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Finland
Sponsor
Novartis Pharma AG
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2004-001981-41

Bipolarity: Lithium/ANti-Convulsant Evaluation

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Italy
Sponsor
UNIVERSITY OF OXFORD
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2021-000862-14

Effects of low dose Aspirin in Bipolarity – a randomized controlled trial (the A-Bipolar RCT)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Denmark
Sponsor
Copenhagen Affective Disorder research Center (CADIC),
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-001233-16

Efficacy of Aripiprazole in Combination with Lithium or Valproate in the Long Term Treatment of Mania in Patients with Bipolarity type I Partially Nonresponsive to Lithium or Valproate Monotherapy...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Czechia
Sponsor
Bristol-Myers Squibb International Corporation
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2004-000202-49

Efficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolarity type I Partially Nonresponsive to Valproate or Lithium Monotherapy Revised...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Estonia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Estonia, Hungary, Italy, ...
Sponsor
Bristol-Myers Squibb International Corporation
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.